There are 2789 resources available
101P - The landscape of MET alterations in European cancer patients
Presenter: Jürgen Wolf
Session: ePoster Display
102P - NTRK test usage practices in Europe and Asia: Findings from a real-world study
Presenter: Kriti Jindal
Session: ePoster Display
103P - Rate of BRCA1/2 pathogenic variants according to family and personal history of cancer in a large cohort of triple-negative breast cancer (TNBC) patients (pts) younger than 60 years of age
Presenter: Stefania Zovato
Session: ePoster Display
104P - Matching-adjusted indirect comparison for treatment of NTRK fusion cancer with larotrectinib versus entrectinib
Presenter: Jesus Garcia-Foncillas
Session: ePoster Display
105P - Prognostic value of the NTRK fusion biomarker in the Netherlands
Presenter: Irene Santi
Session: ePoster Display
106P - Prognostic impact of memory CD8(+) T cells on immunotherapy in human cancers: A systematic review and meta-analysis
Presenter: Yao Jin
Session: ePoster Display
107P - Co-mutation of IDH1 and DNA damage repair genes in patients with hepatobiliary cancer implicates longer overall survival
Presenter: Guangming Li
Session: ePoster Display
108P - A comprehensive pan-cancer study of fusions in Chinese cancer patients
Presenter: Mingwei Li
Session: ePoster Display
109P - A novel, comprehensive glimpse at NY-ESO-1 expression, mRNA to protein translation, & potential impact on clinical studies
Presenter: Kristin Blouch
Session: ePoster Display
110P - Novel genetic variants of CBS and COMT in the transsulfuration pathway genes are associated with survival of non-small cell lung cancer patients
Presenter: Yufeng Wu
Session: ePoster Display